A Population Pharmacokinetic and Pharmacodynamic Evaluation of Pralatrexate in Patients With Relapsed or Refractory Non-Hodgkin's or Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

A Population Pharmacokinetic and Pharmacodynamic Evaluation of Pralatrexate in Patients With Relapsed or Refractory Non-Hodgkin's or Hodgkin's Lymphoma

Published:2009-05-27 Issue:2 Volume:86 Page:190-196
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Mould D R,Sweeney K,Duffull S B,Neylon E,Hamlin P,Horwitz S,Sirotnak F,Fleisher M,Saunders M E,O'Connor O A

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project

2. Activity of a Novel Anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against Human Lymphoma is Superior to Methotrexate and Correlates with Tumor RFC-1 Gene Expression

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind;Anti-Cancer Agents in Medicinal Chemistry;2023-02

2. A novel and ultrasensitive electrochemical DNA biosensor for pralatrexate detection;Analytical Methods;2023

3. Three efficient chemometrics assisted fluorimetric detection methods for interference-free, rapid, and simultaneous determination of ibrutinib and pralatrexate in various complicated biological fluids;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2021-05

4. Pralatrexate injection for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma;Expert Review of Hematology;2020-04-26

5. Development of new agents for peripheral T-cell lymphoma;Expert Opinion on Biological Therapy;2019-01-29